Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook

JPST Editorial Board

Editor-in-Chief

Richard V. Levy, PhD 

Dr. Levy became the ninth Editor-in-Chief of PDA Journal of Pharmaceutical Science and Technology  in June 2018. Prior to that, he served as PDA's Senior Vice President of Scientific and Regulatory Affairs.  In this capacity, he was responsible for directing and managing the scientific, technical, regulatory affairs, and quality activities at PDA. He was also responsible for the Association publications: PDA JPST, PDA technical reports and research surveys, and PDA Letter. Dr. Levy’s other key activities included working with PDA members to prepare and write consensus positions on proposed international regulations and guidance documents, and developing the scientific content of PDA’s global meetings and forums.  

Prior to joining PDA, Dr. Levy was Corporate Vice President and General Manager of Parexel Consulting. Prior to joining Parexel Consulting, Dr. Levy was with Millipore Corporation (now MilliporeSigma) for 16 years in a variety of business, R&D, regulatory, and quality systems senior management positions. He was Chair-elect of the PDA Board of Directors (2004-2005) and served on that Board from 1999-2005.  

Dr. Levy received his B.A. in Biology from Colby College (Waterville, ME) and an M.A. in Biology from Clark University (Worcester, MA). He received his Ph.D. in Environmental Health Sciences from Worcester Polytechnic Institute (Worcester, MA).  

Associate Editors 

 

Shanker Gupta, PhD, U.S. National Institutes of Health

 

 

 

Editorial Board 

James Akers, PhD, Consultant  Jose Caraballo, MBA/MS, Bayer AG 

Dayue Chen, PhD, Eli Lilly and Company
H. Gregg Claycamp, PhD, U.S. FDA 
Tony Cundell, PhD, Consultant Fenton Fong, Msc, xCellarate
Shanker Gupta, PhD, U.S. National Institutes of Health  Ankur Kulshrestha, PhD,  Brstol Myers Squibb 
Kelvin Lee, PhD, NIMBL
 
Duncan Low, PhD, Claymore Biopharm LLC
Hanns-Christian Mahler, PhD, Lonza AG Neha Pardeshi, PhD, Amgen 
Wendy R. Saffell-Clemmer, MS, Baxter BioPharma Solutions LLC  Tim Sandle, PhD, Bio Products Laboratory Limited
Alicja Sobantka , PhD, Octapharma István Szikora, MBA/MS, Sandoz International GmbH
Edward C. Tidswell, PhD, Merck & Co., Inc. Henrietta Vinnerås, MSc, Fresenius Kabi AB 
Kelly Waldron, PhD, ValSource Wesley Workman, PhD
 Glenn Wright, PDA Earl Zablackis, PhD, Sanofi Pasteur
 
Steve Zdravkovic, BS, PPD 
 
Qingyu Zeng, PhD, West Pharmaceutical Services, Inc.

 

Daniele Zuccato, MS, SCHOTT AG 

 

 

PDA, Inc., Leadership 

Chair 

Jette Christensen, PhD, Novo Nordisk 

Chair-elect 

Susan Schniepp, RCA 

Treasurer 

Melissa Seymour, Biogen 

Secretary 

Emma Ramnarine, Roche Pharma 

Immediate Past Chair  

Rebecca Devine, PhD, Regulatory Consultant  

Directors 

Masahiro Akimoto, Otsuka Pharmaceutical Factory, Inc. 
Barbara Allen, PhD, Eli Lilly & Company 
Michael Blackton, Adaptimmune
Bettine Boltres, West PharmaceuticalServices
Tia Bush, Amgen  
Ghada Haddad, Merck & Co., Inc./Merck Sharp & Dohme 
Joyce Hansen, Johnson & Johnson
Stephan Krause, AstraZeneca Diagnostics 
Mary Oates, PhD, Pfizer  
Stephan Roenninger, Roche Pharma
Mathias Romacker, Pfizer (ret.)
Anil Sawant, Merck & Co., Inc./Merck Sharp & Dohme 
 

PDA Staff Liaisons 

Richard Johnson, President & CEO 
Walter Morris, Sr. Director, Publishing 

 

 

 

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2021 PDA Journal of Pharmaceutical Science and Technology ISSN: 1079-7440

Powered by HighWire